These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3036033)

  • 21. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
    Karlsson E
    Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug-induced agranulocytosis, erythro-aplasia and aplastic anemia].
    Soppi E; Viikari J; Kätkä K; Pelliniemi TT; Aalto-Setälä L; Antila V; Jalava S; Kaarsalo E; Koskelainen J; Laurila S
    Duodecim; 1986; 102(3):163-71. PubMed ID: 3081320
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias.
    Michelson EL; McGeehin FC; Levin BK
    Angiology; 1988 Jul; 39(7 Pt 2):647-54. PubMed ID: 3044199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting plasma procainamide concentrations resulting from a sustained-release preparation.
    DiPersio DM; Chow MS
    Clin Pharm; 1985; 4(2):186-91. PubMed ID: 3987218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained release procainamide in patients with myocardial infarction.
    Birkhead J; Evans T; Mumford P; Martinez E; Jewitt D
    Br Heart J; 1976 Jan; 38(1):77-80. PubMed ID: 1252299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Procainamide-induced pseudo-obstruction in a diabetic patient.
    Peterson AM; Conrad SD; Bell JM
    DICP; 1991 Dec; 25(12):1334-5. PubMed ID: 1815428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pure red-cell aplasia associated with cotrimoxazole].
    Serrate San Miguel G; Franco Comet P; Puigbó Casañé MD; Font Creus B
    Med Clin (Barc); 1985 Mar; 84(8):334. PubMed ID: 3872389
    [No Abstract]   [Full Text] [Related]  

  • 28. Cerebellar ataxia due to procainamide toxicity.
    Schwartz AB; Klausner SC; Yee S; Turchyn M
    Arch Intern Med; 1984 Nov; 144(11):2260-1. PubMed ID: 6497531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Febrile reactions to procainamide.
    Knight PO; Baumann DP
    JFMA; 1972 Apr; 59(4):34. PubMed ID: 5033037
    [No Abstract]   [Full Text] [Related]  

  • 30. Agranulocytosis due to new sustained-release procainamide.
    Berger BE; Hauser DJ
    Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II study of procarbazine in small cell carcinoma of the lung.
    Pedersen AG; Sörenson S; Aabo K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):273-5. PubMed ID: 6275988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug induced pulmonary disease. Diffuse interstitial pneumonitis during chemoradiotherapy for small cell carcinoma of the lung. Two cases (author's transl)].
    Riou R; Duvillard P; Touraine R
    Poumon Coeur; 1982; 38(1):57-62. PubMed ID: 6283505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations.
    Meyers DG; Gonzalez ER; Peters LL; Davis RB; Feagler JR; Egan JD; Nair CK
    Am Heart J; 1985 Jun; 109(6):1393-5. PubMed ID: 4003250
    [No Abstract]   [Full Text] [Related]  

  • 34. Aplastic anemia and pure red cell aplasia.
    Dessypris EN
    Curr Opin Hematol; 1994 Mar; 1(2):157-61. PubMed ID: 9371275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative bioavailability of two oral sustained-release procainamide products.
    Baker BA; Reynolds JR; Gleckel L; A'Zary E; Bodenheimer MM
    Clin Pharm; 1988 Feb; 7(2):135-8. PubMed ID: 3349748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmaceutical and pharmacokinetic principles in the formulation of a sustained-release procainamide tablet.
    Dahl SG; Fremstad D; Jacobsen S; Kvaleid I; Landmark KH; Lunde PK; Marthinsen AA; Nådland KJ; Waaler T
    Pharm Acta Helv; 1976; 51(7-8):204-8. PubMed ID: 967912
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of preparations increasing the antiblastic action of antitumor substances on the results of postoperative chemotherapy in lung cancer].
    Mantsurov NE
    Vrach Delo; 1982 Apr; (4):88-91. PubMed ID: 6285619
    [No Abstract]   [Full Text] [Related]  

  • 38. [Case of pure red cell aplasia due to cell-mediated suppression of erythropoiesis associated with Aldomet administration].
    Okamoto S; Nakazawa H; Ohnishi S; Handa S; Nakamura Y; Toyama K
    Rinsho Ketsueki; 1983 Mar; 24(3):271-5. PubMed ID: 6887533
    [No Abstract]   [Full Text] [Related]  

  • 39. [Isolated erythroid aplasia during immunosuppressive therapy with azathioprine after kidney transplantation].
    Flury W; Montandon A
    Schweiz Med Wochenschr; 1980 Nov; 110(44):1614-6. PubMed ID: 7006074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.